KLA peptide
KLA peptide is a naturally occurring Antibiotic peptide that is nontoxic outside of cells but is toxic when it enters into the interior of targeted cells. KLA peptide can induce cell Apoptosis by disrupting mitochondrial membranes and activating Caspase. MG1-KLA, formed by the coupling of KLA peptide with MG1, can selectively induce apoptosis in pro-inflammatory microglia. KLA peptide can be used for the research of liver fibrosis. KLA peptide can be used for the research of neonatal hypoxic-ischemic encephalopathy.
For research use only. We do not sell to patients.
- CAS No.: 184240-26-4
- Formula: C72H138N20O15
- Molecular Weight:1523.99
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
When acting alone, the KLA peptide (in FITC-KLA form; 50-200 μM; 30 min) exhibits negligible cell-penetrating activity in HSC-T6 cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
CAS No. 184240-26-4
-
Molecular Weight 1523.99
-
Formula C72H138N20O15
-
Sequence
Lys-Leu-Ala-Lys-Leu-Ala-Lys-Lys-Leu-Ala-Lys-Leu-Ala-Lys
-
Sequence Shortening
KLAKLAKKLAKLAK
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Guo Z, et al. Specific hepatic stellate cell-penetrating peptide targeted delivery of a KLA peptide reduces collagen accumulation by inducing apoptosis. J Drug Target. 2017;25(8):715-723. [Content Brief]
[2]. Zen R, et al. Pro-inflammatory microglia-targeted peptide therapy ameliorates neonatal hypoxic-ischemic encephalopathy in mice. Mol Ther. 2025;33(7):3177-3194. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)